IRF2

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA030813

Antibody CAB032306

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Weak to moderate nuclear staining was observed in a majority of malignant cells. Malignant gliomas exhibited strong staining. Skin, testicular and prostate cancers were in mainly negative.Most cancers exhibited moderate to strong nuclear immunoreactivity. Testicular cancers and several cases of melanomas, stomach and liver cancers were weakly stained or negative.

Validation

Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected